Document is current
Any future updates will be listed below
-
Authors
Bohn, Amelie https://orcid.org/0009-0009-1879-5589
Teubner, Fiona S.
Tauber, Simone C.
Waschbisch, Anne
-
Funding
Funding for this research was provided by:
RWTH Aachen University
- License Information
-
More Information
Article History
Received: 7 March 2026
Accepted: 16 June 2026
First Online: 29 June 2026
Declarations
:
: This retrospective study was conducted in accordance with the principles of the Declaration of Helsinki and approved by the institutional ethics committee of the University Hospital RWTH Aachen (approval number: 23-181, date: 10.07.2023).
: Due to the retrospective nature of the study and the use of anonymized data, the requirement for informed consent was waived by the ethics committee.
: Not applicable
: A. Bohn received travel and speaker honoraria from Novartis, Merck and Roche; F.S. Teubner reports no disclosures relevant to the manuscript; A. Waschbisch received travel and speaker honoraria from CSL Behring, Merck, and Roche; S.C. Tauber served on the scientific advisory board for Roche and Merck and received travel and speaker honoraria from Novartis, Teva, Merck, Roche and Biogen.
